Articles with "tnbcs" as a keyword



Photo by nate_dumlao from unsplash

Cardiovascular Pathology

Sign Up to like & get
recommendations!
Published in 2017 at "Laboratory Investigation"

DOI: 10.1038/labinvest.2016.163

Abstract: 308 Androgen Receptor Expression Is Higher in CK5/6 Negative versus CK5/6 Positive Triple-Negative Breast Cancers Tao Zuo, Ali Cicek, Olivia L Snir, Yuanxin Liang, Malini Harigopal. Yale School of Medicine, New Haven, CT; Tufts Medical… read more here.

Keywords: ck5 positive; pathology; tnbcs; expression ... See more keywords
Photo by nci from unsplash

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

Sign Up to like & get
recommendations!
Published in 2022 at "NPJ Breast Cancer"

DOI: 10.1038/s41523-021-00371-0

Abstract: Triple-negative breast cancer (TNBC) patients with mesenchymal stem-like (MSL) subtype have responded poorly to chemotherapy whereas patients with basal-like 1 (BL1) subtype achieved the best clinical response. In order to gain insight into pathways that… read more here.

Keywords: breast; tnbcs; breast cancer; tocilizumab ... See more keywords
Photo by cedrikwesche from unsplash

Convolutional neural network for biomarker discovery for triple negative breast cancer with RNA sequencing data.

Sign Up to like & get
recommendations!
Published in 2023 at "Heliyon"

DOI: 10.2139/ssrn.4247609

Abstract: Triple negative breast cancers (TNBCs) are tumors with a poor treatment response and prognosis. In this study, we propose a new approach, candidate extraction from convolutional neural network (CNN) elements (CECE), for discovery of biomarkers… read more here.

Keywords: tnbcs; triple negative; convolutional neural; negative breast ... See more keywords

Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Oncology"

DOI: 10.3389/fonc.2022.804466

Abstract: Background In triple-negative breast cancer (TNBC), PDL1/PD1-directed immunotherapy is effective in less than 20% of patients. In our preliminary study, we have found CSPG4 to be highly expressed together with PDL1 in TNBCs, particularly those… read more here.

Keywords: tnbcs; tp53 aberrant; pdl1; tnbc ... See more keywords